📊 Score Breakdown
Offering Ability
85
Cash Runway
0
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
31%
📉 Score Deterioration
40%
• Score rose 16 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($200M, 53% of market cap)
• Active ATM program with $200M remaining capacity
💹 Market Data
Market Cap$374.96M
Shares Outstanding94.45M
Float85.99M
Cash$150.70M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 1.3% shares (2025Q4 vs prior)
222 institutional holders · 93.17M shares
#1
BlackRock, Inc.
15.30M shares
#2
VANGUARD GROUP INC
8.23M shares
#3
MILLENNIUM MANAGEMENT LLC
6.70M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest8.33M
Days to Cover3.8
% of Float9.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
EFFECT
EFFECT
Mar 04, 2026
424B3
ATM
Mar 04, 2026
4
INSIDER TRANSACTION
Mar 02, 2026
4
INSIDER TRANSACTION
Feb 27, 2026
S-3
SHELF
Feb 24, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for MYGN
📊 MYGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 MYGN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.